Delivery Order SPE2DB20D3505-SPE2DB23FU2H8

Award Date 6/6/23
Potential Completion Date 6/7/23
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE Vaginal Rings. The contract has a ceiling value of $2,395.52 and a period of performance through July 19, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,563.63 firm fixed-price contract is for the supply of Etonogestrel-EE Vaginal Rings, a type of pharmaceutical product. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for providing a wide range...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Etonogestrel-EE Vaginal Rings, a contraceptive product, with a ceiling value of $1,457.98 and a performance period ending on March 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 IDC...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of Etonogestrel-EE Vaginal Rings, a pharmaceutical product. The contract has a ceiling value of $1,798.24 and an ultimate completion date of March 29, 2023. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Etonogestrel-EE vaginal rings. The award has a ceiling value of $2,303.58 and a completion date of April 24, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the supply of Etonogestrel-EE Vaginal Rings. The order has a firm fixed-price contract type and a ceiling value of $1,623.36. The ultimate completion date is August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,729.04 and is for the delivery of ETONOGESTREL-EE VAGINAL RINGS. It is a firm fixed price contract with an ultimate completion date of August 12, 2024. The award was made on August 9, 2024, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Etonogestrel-EE Vaginal Rings, a type of contraceptive device, with a ceiling value of $1,592.44 and a completion date of September 23, 2024. The contract is a firm-fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of etonogestrel-ethinyl estradiol vaginal rings, with a ceiling value of $1,655.52 and a period of performance through August 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ETONOGESTREL-EE VAGINAL RINGS. The contract has a ceiling value of $1,448.40 and a completion date of August 21, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its extensive supply chain network, provides a wide range of prescription medications,...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FU2H8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE vaginal rings. The contract has a ceiling value of $1,896.96 and a completion date of June 7, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:25 AM